Description

You are being asked to take part in this research study because you have advanced Non-Small Cell Lung Cancer (NSCLC).
The purpose of this study is to assess the safety of ASP8273 and to determine a safe dose of the study drug in patients with advanced Non-Small Cell Lung Cancer (NSCLC).
The information collected in this study is necessary to find out whether the treatment tested is effective and safe. The information about you will be kept anonymous. Information may be used for seeking approval from the regulatory authorities to market the medicine for NSCLC. It may also be used in reports of the study or for scientific presentations. Astellas may also use the information from this study for future medical research.